| Product Code: ETC8628676 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Malaria Vaccine Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria Malaria Vaccine Market - Industry Life Cycle |
3.4 Nigeria Malaria Vaccine Market - Porter's Five Forces |
3.5 Nigeria Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Nigeria Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.7 Nigeria Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Nigeria Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Nigeria Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of malaria in Nigeria |
4.2.2 Government initiatives to combat malaria |
4.2.3 Growing awareness about the importance of vaccination against malaria |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas |
4.3.2 High cost of vaccines and vaccination programs |
4.3.3 Lack of proper infrastructure for vaccine distribution and storage |
5 Nigeria Malaria Vaccine Market Trends |
6 Nigeria Malaria Vaccine Market, By Types |
6.1 Nigeria Malaria Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Malaria Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Nigeria Malaria Vaccine Market Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021- 2031F |
6.1.4 Nigeria Malaria Vaccine Market Revenues & Volume, By Erythrocytic Vaccine, 2021- 2031F |
6.1.5 Nigeria Malaria Vaccine Market Revenues & Volume, By Multi-Antigen Vaccine, 2021- 2031F |
6.2 Nigeria Malaria Vaccine Market, By Agent |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Malaria Vaccine Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.2.3 Nigeria Malaria Vaccine Market Revenues & Volume, By Plasmodium Vivax, 2021- 2031F |
6.2.4 Nigeria Malaria Vaccine Market Revenues & Volume, By Anopheles Species, 2021- 2031F |
6.3 Nigeria Malaria Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Nigeria Malaria Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.3 Nigeria Malaria Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.4 Nigeria Malaria Vaccine Market Revenues & Volume, By Intradermal, 2021- 2031F |
6.4 Nigeria Malaria Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Nigeria Malaria Vaccine Market Revenues & Volume, By NGO/Non-Profit Organization, 2021- 2031F |
6.4.3 Nigeria Malaria Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 Nigeria Malaria Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 Nigeria Malaria Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Nigeria Malaria Vaccine Market Import-Export Trade Statistics |
7.1 Nigeria Malaria Vaccine Market Export to Major Countries |
7.2 Nigeria Malaria Vaccine Market Imports from Major Countries |
8 Nigeria Malaria Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates |
8.2 Number of government-funded malaria vaccination programs implemented |
8.3 Reduction in malaria-related mortality rates |
8.4 Number of partnerships with international organizations for vaccine distribution |
8.5 Percentage increase in public awareness campaigns about malaria vaccination |
9 Nigeria Malaria Vaccine Market - Opportunity Assessment |
9.1 Nigeria Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Nigeria Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.3 Nigeria Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Nigeria Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Nigeria Malaria Vaccine Market - Competitive Landscape |
10.1 Nigeria Malaria Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Nigeria Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here